Attached files
| file | filename |
|---|---|
| 10-K/A - 10-K/A - INTERCEPT PHARMACEUTICALS, INC. | v408719_10ka.htm |
| EX-3.1 - EXHIBIT 3.1 - INTERCEPT PHARMACEUTICALS, INC. | v408719_exh3x1.htm |
| EX-31.3 - EXHIBIT 31.3 - INTERCEPT PHARMACEUTICALS, INC. | v408719_exh31x3.htm |
Exhibit 31.4
CERTIFICATIONS UNDER SECTION 302
I, Barbara G. Duncan, certify that:
| 1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Intercept Pharmaceuticals, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 30, 2015
/s/ Barbara Duncan
Barbara G. Duncan
Chief Financial Officer
(Principal Financial Officer)